Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma

<div><i>In vivo</i> toxicity results of DDS NPs: (a) survival rate of free dual drugs and DDS NPs, there were 10 mice in each group; (b) the results of pathological examination of the heart and liver treated by dual drugs and DDS NPs. HE stain was used. Magnification was 200x.</div>

Journal of Nanomaterials

fig4

Figure 4

Figure 4: Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma 